• AK2 tyrosine kinase activation
• Increased platelets, megakaryocytes.
• Large and abnormal platelets → bleeding.
• increased platelets → increased PDGF → increased fibroblasts → Primary myelofibrosis (scarring of marrow) common
• Hepatosplenomegaly
• Transformation to AML – Late & Rare.